Cyclacel Pharmaceuticals Inc 6% C.../ US23254L2079 /
07/06/2024 17:32:11 | Diferencia - | Volumen | Bid10:00:00 | Ask10:00:00 | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
7.7000USD | - | 1,717 Volumen de negocios: 12,883.3300 |
6.0000Volumen de oferta: 100 | 12.0000Tamaño/ Volumen/ Formato de Ask: 100 | 10.9700 | 7.7000 |
GlobeNewswire
10:00
Intech Unveils UCITS Fund with Adaptive Volatility and ESG Focus, Anchored by Norway’s Pension Schem...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation I...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
MBUU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Malibu Boats, Inc. Investors w...
GlobeNewswire
10:00
BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patient...
GlobeNewswire
9:01
AMERICAN SALARS COMPLETES PHASE 1 EXPLORATION OF BLACK ROCK SOUTH LITHIUM BRINE PROJECT, NV
GlobeNewswire
9:00
Nokia Report reveals enterprises are scaling private wireless for additional uses cases and industri...
GlobeNewswire
8:55
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página